ישראל -
עברית -
Ministry of Health
יוניק קר ריקבר קונסילר טיפולי לטשטוש כתמים בעור הפנים ולהבהרתם עם חומר הבהרה טיפולי מתקדם
מעבדות דר מלומד - טשטוש כתמים
ישראל -
עברית -
Ministry of Health
אוראל-בי קומפליט משחת שיניים להלבנה עם כדוריות מי-פה -רעננות חזקה
נוגם תמרוקים בעמ - היגיינת הפה
ישראל -
עברית -
Ministry of Health
לשקוטאן משחה
teva israel ltd - methylbenzethonium chloride; paromomycin as sulfate - משחה - methylbenzethonium chloride 12 %w/w; paromomycin as sulfate 15 %w/w - paromomycin - paromomycin - topical treatment of cutaneous leishmaniasis.
ישראל -
עברית -
Ministry of Health
פלאג'יל 250 מג טבליות
sanofi israel ltd - metronidazole - טבליות מצופות פילם - metronidazole 250 mg - metronidazole - metronidazole - trichomonias, acute intestinal amebiasis. infections due to anaerobic bacteria.
ישראל -
עברית -
Ministry of Health
נוקספיל תרחיף
merck sharp & dohme israel ltd - posaconazole - תרחיף - posaconazole 40 mg/ml - posaconazole - posaconazole - noxafil is indicated for use in the treatment of the following fungal infections in adults : - invasive aspergillosis in patients with disease that is refractory to amphotericin b or itraconazole or in patients who are intolerant of these medicinal products - fusariosis in patients with disease that is refractory to amphotericin b or in patients who are intolerant of amphotericin b - chromoblastomycosis and mycetoma in patients with disease that is refractory to itraconazole or in patients who are intolerant of itraconazole - coccidioidomycosis in patients with disease that is refractory to amphotericin b itraconazole or fluconazole or in patients who are intolerant of these medicinal products - oropharyngeal candidiasis : as first - line therapy in patients who have severe disease or are immunocompromised in whom response to topical therapy is expected to be poor. refractoriness is defined as progression of infection or failure to improve after a minimum of 7 days of prior therapeutic doses of effective anti
ישראל -
עברית -
Ministry of Health
ביקאלוטמיד אינובמד 150 מג
inovamed ltd - bicalutamide - טבליות מצופות פילם - bicalutamide 150 mg - bicalutamide - bicalutamide - in patients with locally advanced prostate cancer (t3 - t4 any n m0 t1 -t2 n+ m0), bicalutamide 150 mg is indicated as immediate therapy either alone or as adjuvant to treatment by radical prostatectomy or radiotherapy. the management of patients with locally advanced non-metastatic prostate cancer for whom surgical castration or other medical intervention is not considered appropriate or acceptable